Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-26-154882
Filing Date
2026-04-14
Accepted
2026-04-14 16:06:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d138694d8a12b.htm 8-A12B 12854
  Complete submission text file 0001193125-26-154882.txt   13876
Mailing Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451
Business Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451 508-440-9475
Kailera Therapeutics, Inc. (Filer) CIK: 0002096997 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-43233 | Film No.: 26860882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)